Kathy S. Albain
- Oncology top 0.05%
- Pulmonary and Respiratory Medicine top 0.05%
- Cancer Research top 0.2%
- Molecular Biology top 2%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Co-authors
- John J. CrowleyRobert B. LivingstonJoseph M. UngerCharles A. ColtmanLaura F. HutchinsDavid R. GandaraMichael LeBlancKaren Kelly
- Topics
- Lung Cancer Treatments and Mutations (66 papers)Breast Cancer Treatment Studies (63 papers)Cancer Treatment and Pharmacology (47 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Kathy S. Albain
229 papers receiving 18.5k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Oncology 11.9k
- Pulmonary and Respiratory Medicine 9.2k
- Cancer Research 3.8k
- Molecular Biology 2.9k
- Radiology, Nuclear Medicine and Imaging 2.1k
Countries citing papers authored by Kathy S. Albain
This map shows the geographic impact of Kathy S. Albain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy S. Albain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy S. Albain more than expected).
Fields of papers citing papers by Kathy S. Albain
This network shows the impact of papers produced by Kathy S. Albain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy S. Albain. The network helps show where Kathy S. Albain may publish in the future.
Co-authorship network of co-authors of Kathy S. Albain
This figure shows the co-authorship network connecting the top 25 collaborators of Kathy S. Albain. A scholar is included among the top collaborators of Kathy S. Albain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy S. Albain. Kathy S. Albain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 10 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 15 | |
| 6 | 9 | |
| 7 | 1 | |
| 8 | 32 | |
| 9 | 158 | |
| 10 | 148 | |
| 11 | 145 | |
| 12 | 45 | |
| 13 | 110 | |
| 14 | Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. | 119 |
| 15 | 3 | |
| 16 | 64 | |
| 17 | 421 | |
| 18 | 5 | |
| 19 | Double blind phase III trial of placebo (P) vs. megestrol acetate (MA) 20 mg vs. MA 40 mg as treatment for symptoms of ovarian failure in breast cancer survivors: Initial results of Southwest Oncology Group S9626 | 2 |
| 20 | Age less than 35 is associated with high percent S-phase, abnormal P53, and adverse breast cancer outcome | 9 |
About Kathy S. Albain
Kathy S. Albain is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 234 papers that have together received 19.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (66 papers), Breast Cancer Treatment Studies (63 papers) and Cancer Treatment and Pharmacology (47 papers). The work is most often cited by research in Oncology (11.9k citations), Pulmonary and Respiratory Medicine (9.2k citations) and Cancer Research (3.8k citations). Kathy S. Albain has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John J. Crowley, Robert B. Livingston, Joseph M. Unger, Charles A. Coltman, Laura F. Hutchins, David R. Gandara, Michael LeBlanc, Karen Kelly, Valerie W. Rusch and Andrew T. Turrisi. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.